Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Protagenic Therapeutics (PTIX) has issued an announcement.
In a positive turn for investors, a company has successfully addressed its previous Nasdaq non-compliance issue by maintaining its stock price above the $1.00 minimum bid price for ten consecutive trading days. This accomplishment has resulted in the Nasdaq Listing Qualifications Department closing the deficiency notice, ensuring the company’s continued listing on the exchange and potentially restoring investor confidence in its financial stability.
For detailed information about PTIX stock, go to TipRanks’ Stock Analysis page.
